Transformation of berberine to its demethylated metabolites by the CYP51 enzyme in the gut microbiota
Zhengwei Zhang(Anhui Medical University), Jian‐Dong Jiang(Chinese Academy of Medical Sciences & Peking Union Medical College), Hang Yu(Humboldt-Universität zu Berlin), Ran Peng(Chinese Academy of Medical Sciences & Peking Union Medical College), Jie Fu(Tianjin University), Yan Wang(Fujian Normal University), Lin Cong, Shurong Ma(Dalian Medical University), Pei Han(Chinese Academy of Medical Sciences & Peking Union Medical College), Li‐Bin Pan(Zhejiang Cancer Hospital)
Cited by 47
Related Papers
The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design
|Drug Design Development and Therapy|2021|377
Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiota
|Signal Transduction and Targeted Therapy|2021|315
Berberine reduces insulin resistance through protein kinase C–dependent up-regulation of insulin receptor expression
|Metabolism|2008|265
Abnormal metabolism of gut microbiota reveals the possible molecular mechanism of nephropathy induced by hyperuricemia
|Acta Pharmaceutica Sinica B|2019|217
Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients
|Signal Transduction and Targeted Therapy|2021|210